Faculty
Oncology Division

Todd A. Fehniger, MD, PhD
Professor
Department of Medicine
Oncology Division
Stem Cell Biology
Bone Marrow Transplantation & Leukemia
Clinical Interests
- Lymphoma
- Leukemia
- Immunotherapy
- Hematopoietic cell transplantation
Research Interests
- Innate immunity
- Natural killer cell biology
- Micro RNAs
- Cytokines
- Natural killer cell based therapeutics
Contact
- 314-747-1385 (office)
- 314-747-1547 (lab)
- 314-362-9333 (fax)
- tfehnige@wustl.edu
- Division of Oncology
Mail Stop 8007-0057-06
Washington University
660 South Euclid Avenue
St. Louis, MO 63110 - Room 638 Southwest Tower (office)
- Room 634 Southwest Tower (lab)
- Fehniger Laboratory
Biosketch
Education | |
---|---|
1994 | BS in Biological Sciences with High Distinction, State University of New York (SUNY), Buffalo, NY |
2000 | PhD in Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, College of Medicine and Public Health, Columbus, OH |
2002 | MD, The Ohio State University, College of Medicine and Public Health, Columbus, OH |
Post-graduate Training | |
2002-2004 | Intern and Resident, Internal Medicine, Physician Scientist Training Pathway, Barnes-Jewish Hospital, Washington University School of Medicine, St. Louis, MO |
2004-2008 | Fellow, Hematology and Oncology, Washington University School of Medicine, St. Louis, MO |
Academic Positions & Employment | |
2008-2014 | Assistant Professor, Department of Medicine, Washington University School of Medicine, St. Louis, MO |
2015-2020 | Associate Professor, Department of Medicine, Washington University School of Medicine, St. Louis, MO |
2020-present | Professor, Department of Medicine, Washington University School of Medicine, St. Louis, MO |
University & Hospital Appointments & Committees | |
2008-present | Member, Siteman Cancer Center, Hematopoietic Development and Malignancy Program; Lymphoma Program Co-Leader |
2008-present | Member, Division of Biology and Biomedical Sciences, Immunology Program, Washington University |
2008-present | Member, Institute for Clinical and Translational Sciences (ICTS), Washington University |
2009-2011 | Data Safety Monitoring Committee for investigator initiated clinical trial 07-0916: “Phase I trial of intravenous Decitabine in combination with Arsenic trioxide and Ascorbic acid in patients with myelodysplastic syndromes” |
2009-2013 | Reviewer, Translational Oncology Group Seed Funding, Division of Oncology |
2009 | Reviewer, BJHF/ICTS Clinical and Translational Research Funding Program |
2010-2013 | Siteman Cancer Center Shared Resource Review Committee |
2014-2018 | Leukemia SPORE DRP Review Committee |
2014-2017 | Reviewer, BJHF/ICTS Clinical and Translational Research Funding Program |
2014-2019, 2021 | Member, Siteman Cancer Center Investment Program Study Section |
2014-present | Member, WUSM Center for Human Immunology and Immunotherapy Programs (CHIIPs) |
2017-present | K12 Training Grant Review Committee |
2017-2018 | KL2 Training Grant Review Committee |
2018-present | Scientific Co-Director, Center for Gene and Cellular Immunotherapy, Division of Oncology, Department of Medicine, Washington University School of Medicine |
2018-present | Director, Biological Therapy Core Facility, Siteman Cancer Center, Washington University School of Medicine |
Board Certification | |
2006 | ABIM Certified, Internal Medicine |
2009, 2019 | ABIM Certified, Medical Oncology |
National or International Awards | |
1996 | Howard Hughes Medical Institute (HHMI) Research Fellowship for Medical Students |
1999, 2001 | American Society of Hematology (ASH) Travel Award |
2000 | ASH Medical Student (Trainee) Award |
2000 | American Association of Immunologists (AAI)-Huang Foundation Trainee Achievement Award |
2007 | American Society of Clinical Oncology (ASCO) Young Investigator Award |
2007 | Future Leader in Hematology Award (Celgene) |
2008 | ASCO Merit Award |
2008 | HHMI Physician Scientist Early Career Award |
2008 | Edward Mallinckrodt, Jr. Foundation Award |
2009 | ASH Scholar Award (Basic Science, Junior Faculty) |
2012 | V Scholar Award, V Foundation for Cancer Research |
2013 | ASH Bridge Grant Program Award (declined when R01 funded) |
2013 | Follicular Lymphoma Pathway Award, Lymphoma Research Foundation |
2014 | Gabrielle's Angel Foundation Medical Award |
2014 | AAI Junior Faculty Travel Award |
2016 | Elected Member, American Society for Clinical Investigation (ASCI) |
2017 | Children’s Discovery Institute, Interdisciplinary Award |
2017 | V Scholar Translational Research Award, V Foundation for Cancer Research |
2018 | Siteman Cancer Center "Rock Doc" Award |
2018 | Siteman Cancer Center Lymphoma Team Science Award |
Editorial Responsibilities | |
2015-present | Review Editor, Frontiers in Molecular Innate Immunity |
2015 | Review Editor, Frontier in Immunology, NK cell biology |
2015-2018 | Editorial Board, Blood |
2016-2018 | Editorial Board, European Journal of Immunology |
2018-2023 | Deputy Editor, The Journal of Immunology |
2018 | Editor, Wintrobe’s Clinical Hematology, Edition 14 (Greer, Arber, Rodgers, Means, Appelbaum, Dispenzieri, Glader, List, Fehniger, editors). Wolters Kluwer, 2018 |
Peer-Review Service (Selected) | |
2013 | NIH/NIAID Human Immunology Project Consortium Grant Reviewer |
2013 | Leukemia and Lymphoma Society, Quest for the Cures Study Section Member |
2016 | NIH/NIAID UM1 Martin Delany Collaboratory to Cure HIV, Study Section Member |
2017 | Leukemia and Lymphoma Society, Career Development Program Study Section Member |
2017 | NIH/NIAID P01 Special Emphasis Panel (ZAI1-AMC-A-M1) Study Section Member |
2019 | NIH/NCI R01/R21 Immunotherapy and U54 Pediatric Immunotherapy Study Sections |
2020 | Leukemia and Lymphoma Society, SCOR External Site Reviewer for Baylor |
2021 | National Cancer Institute, P01 Study Section, Ad Hoc Member |
2021 | Leukemia and Lymphoma Society, Career Development Program, Study Section |
Professional Societies & Organizations | |
2004-present | American Society of Hematology 2018-2023: ASH Scientific Committee on Immunology and Host Defense |
2004-present | American Society for Transplantation and Cellular Therapy |
2008-present | Society for Natural Immunity 2018-2021: President-Elect 2021-2024: President |
2008-present | Alliance Cooperative Group Lymphoma Committee, Member Lymphoma Translational Sciences, Vice Chair |
2010-present | American Association of Immunologists |
2010-present | American Association for Cancer Research 2013: AACR Annual Meeting Education Committee, Member |
2014-present | Site Co-PI, Clinical Immunotherapy Trials Network (CITN) |